[1]
|
Zhang, T., Jiang, Y., Zhang, S., et al. (2020) The Association between Homocysteine and Ischemic Stroke Subtypes in Chinese: A Meta-Analysis. Medicine (Baltimore), 99, e19467. https://doi.org/10.1097/MD.0000000000019467
|
[2]
|
Saba, L., Cau, R., Spinato, G., et al. (2024) Carotid Stenosis and Cryptogenic Stroke: The Evidence from the Imaging-Based Studies Carotid Stenosis and Cryptogenic Stroke. Jour-nal of Vascular Surgery.
https://doi.org/10.1016/j.jvs.2024.01.004
|
[3]
|
Ma, Y.Z.X., Zhang, W., Liu, L., Wang, Y., Fang, R. and Wang, Y. (2010) Homocysteine and Ischemic Stroke Subtype: A Relationship Study in Chinese Patients. Neurological Research, 32, 636-641.
https://doi.org/10.1179/016164109X12445616596445
|
[4]
|
Wang, Y., Bai, L., Li, X., Yi, F., et al. (2023) Fibrino-gen-to-Albumin Ratio and Clinical Outcomes in Patients with Large Artery Atherosclerosis Stroke. Journal of the Amer-ican Heart Association, 12, e030837.
https://doi.org/10.1161/JAHA.123.030837
|
[5]
|
Rosário, M. and Fonseca, A. (2023) Update on Biomarkers Asso-ciated with Large-Artery Atherosclerosis Stroke. Biomolecules, 13, Article No. 1251. https://doi.org/10.3390/biom13081251
|
[6]
|
Chaturvedi, S. (2023) Diagnosis and Management of Large Artery Atherosclerosis. Continuum (Minneapolis, Minn.), 29, 486-500. https://doi.org/10.1212/CON.0000000000001212
|
[7]
|
Libby, P., Loscalzo, J., Ridker, P.M., et al. (2018) Inflam-mation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. Journal of the American Col-lege of Cardiology, 72, 2071-2081.
https://doi.org/10.1016/j.jacc.2018.08.1043
|
[8]
|
Libby, P. (2021) Inflammation in Atherosclerosis—No Longer a Theory. Clinical Chemistry, 67, 131-142.
https://doi.org/10.1093/clinchem/hvaa275
|
[9]
|
Libby, P. (2021) The Changing Landscape of Atherosclerosis. Na-ture, 592, 524-533.
https://doi.org/10.1038/s41586-021-03392-8
|
[10]
|
Björkegren, J. and Lusis, A. (2022) Atherosclerosis: Recent De-velopments. Cell, 185, 1630-1645.
https://doi.org/10.1016/j.cell.2022.04.004
|
[11]
|
Butcher, M., Wu, C., Waseem, T. and Galkina, E.V. (2016) CXCR6 Regulates the Recruitment of Pro-Inflammatory IL-17A-Producing T Cells into Atherosclerotic Aortas. International Immunology, 28, 255-261.
https://doi.org/10.1093/intimm/dxv068
|
[12]
|
Shibata, M.A., Shibata, E., Maemura, K., Kondo, Y. and Harada-Shiba, M. (2017) Pathological and Molecular Analyses of Atherosclerotic Lesions in ApoE-Knockout Mice. Medical Molecular Morphology, 50, 130-144.
https://doi.org/10.1007/s00795-017-0154-y
|
[13]
|
Petit, S.J., Wise, E.L., Chambers, J.C., Sehmi, J., Chayen, N.E., Kooner, J.S. and Pease, J.E. (2011) The CXCL16 A181V Mutation Selectively Inhibits Monocyte Adhesion to CXCR6 but Is Not Associated with Human Coronary Heart Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 31, 914-920.
https://doi.org/10.1161/ATVBAHA.110.220558
|
[14]
|
Jovanovic, I.Z.M., Djuric, T., Popovic, M., Alavantic, D. and Stankovic, A. (2015) CXCL16 in Vascular Pathology Research: From Macro Effects to microRNAs. Journal of Atherosclerosis and Thrombosis, 22, 1012-1024.
https://doi.org/10.5551/jat.29942
|
[15]
|
Andersen, T., Ueland, T., Ghukasyan, L.T., Akerblom, A., et al. (2019) C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes. Arteriosclerosis, Thrombosis, and Vascular Biology, 39, 2402-2410. https://doi.org/10.1161/ATVBAHA.119.312633
|
[16]
|
Libby, P., Ridker, P.M. and Maseri, A. (2002) Inflammation and Atherosclerosis. Circulation, 105, 1135-1143.
https://doi.org/10.1161/hc0902.104353
|
[17]
|
Fredman, G. and MacNamara, K.C. (2021) Atherosclerosis Is a Major Human Killer and Non-Resolving Inflammation Is a Prime Suspect. Cardiovascular Research, 117, 2563-2574. https://doi.org/10.1093/cvr/cvab309
|
[18]
|
Geovanini, G. and Libby, P. (2018) Atherosclerosis and Inflammation: Overview and Updates. Clinical Science (London, England: 1979), 132, 1243-1252. https://doi.org/10.1042/CS20180306
|
[19]
|
Engelen, S.E., Robinson, A.J.B., Zurke, Y.X. and Monaco, C. (2022) Therapeutic Strategies Targeting Inflammation and Immunity in Atherosclerosis: How to Proceed? Nature Reviews Car-diology, 19, 522-542.
https://doi.org/10.1038/s41569-021-00668-4
|
[20]
|
Borst, O., Munzer, P., Gatidis, S., Schmidt, E.M., et al. (2012) The Inflammatory Chemokine CXC Motif Ligand 16 Triggers Platelet Activation and Adhesion via CXC Motif Receptor 6-Dependent Phosphatidylinositide 3-Kinase/Akt Signaling. Circulation Research, 111, 1297-1307. https://doi.org/10.1161/CIRCRESAHA.112.276444
|
[21]
|
Kim, M.J., Sun, H.J., Song, Y.S., Yoo, S.K., Kim, Y.A., Seo, J.S., Park, Y.J. and Cho, S.W. (2019) CXCL16 Positively Correlated with M2-Macrophage Infiltration, Enhanced Angiogenesis, and Poor Prognosis in Thyroid Cancer. Scientific Reports, 9, Article No. 13288. https://doi.org/10.1038/s41598-019-49613-z
|
[22]
|
Han, E.C., Lee, J., Ryu, S.W. and Choi, C. (2014) Tu-mor-Conditioned Gr-1(+)CD11b(+) Myeloid Cells Induce Angiogenesis through the Synergistic Action of CCL2 and CXCL16 in Vitro. Biochemical and Biophysical Research Communications, 443, 1218-1225. https://doi.org/10.1016/j.bbrc.2013.12.117
|
[23]
|
Gao, Q., Zhao, Y.J., Wang, X.Y., Qiu, S.J., et al. (2012) CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Out-comes in Hepatocellular Carcinoma. Cancer Research, 72, 3546-3556. https://doi.org/10.1158/0008-5472.CAN-11-4032
|
[24]
|
Isozaki, T., Arbab, A.S., Haas, C.S., Amin, M.A., Arendt, M.D., Koch, A.E. and Ruth, J.H. (2013) Evidence That CXCL16 Is a Potent Mediator of Angiogenesis and Is Involved in Endothelial Progenitor Cell Chemotaxis: Studies in Mice with K/BxN SERUM-INDUCED ARTHRITis. Arthritis and Rheumatism, 65, 1736-1746.
https://doi.org/10.1002/art.37981
|
[25]
|
Li, C.H., Xu, L.L., Zhao, J.X., Sun, L., Yao, Z.Q., Deng, X.L., Liu, R., Yang, L., Xing, R. and Liu, X.Y. (2016) CXCL16 Upregulates RANKL Expression in Rheumatoid Arthritis Synovial Fibroblasts through the JAK2/STAT3 and p38/MAPK Signaling Pathway. Inflammation Research, 65, 193-202. https://doi.org/10.1007/s00011-015-0905-y
|
[26]
|
Korbecki, J., Bajdak-Rusinek, K., Kupnicka, P., et al. (2021) The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases. International Journal of Molecular Sciences, 22, Article No. 3490.
https://doi.org/10.3390/ijms22073490
|
[27]
|
Darwish, M.A., Abo-Youssef, A.M., Messiha, B.A.S., Abo-Saif, A.A. and Abdel-Bakky, M.S. (2021) Resveratrol Inhibits Macrophage Infiltration of Pancreatic Islets in Streptozoto-cin-Induced Type 1 Diabetic Mice via Attenuation of the CXCL16/NF-kappaBeta p65 Signaling Pathway. Life Sciences, 272, Article ID: 119250.
https://doi.org/10.1016/j.lfs.2021.119250
|
[28]
|
Lee, S.C., Lee, Y.J., Choi, I., Kim, M. and Sung, J.S. (2021) CXCL16/CXCR6 Axis in Adipocytes Differentiated from Human Adipose Derived Mesenchymal Stem Cells Regulates Macrophage Polarization. Cells, 10, Article No. 3410.
https://doi.org/10.3390/cells10123410
|
[29]
|
Mitsuoka, H., Toyohara, M., Kume, N., Hayashida, K., Jinnai, T., Tanaka, M. and Kita, T. (2009) Circulating Soluble SR-PSOX/CXCL16 as a Biomarker for Acute Coronary Syn-drome-Comparison with High-Sensitivity C-Reactive Protein. Journal of Atherosclerosis and Thrombosis, 16, 586-593. https://doi.org/10.5551/jat.1081
|
[30]
|
Jansson, A.M., Aukrust, P., Ueland, T., Smith, C., Omland, T., Hartford, M. and Caidahl, K. (2009) Soluble CXCL16 Predicts Long-Term Mortality in Acute Coronary Syndromes. Circulation, 119, 3181-3188.
https://doi.org/10.1161/CIRCULATIONAHA.108.806877
|
[31]
|
Brake, A., Heskett, C., Alam, N., Fry, L., Le, K., Mahnken, J.D. and Abraham, M. (2024) Glycoprotein Inhibitors as a First Line Rescue Treatment after Unsuccessful Recanalization of Endovascular Thrombectomy: A Systematic Review and Meta-Analysis. Interventional Neuroradiology: Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences. https://doi.org/10.1177/15910199241226470
|
[32]
|
Li, Y., Chen, S., Bao, Q., Yang, M. and Li, J. (2023) Re-al-World Safety and Efficacy Endovascular Treatment versus Standard Medical Treatment for Basilar Artery Occlusion: A Systematic Review and Meta-Analysis. Clinical Neurology and Neurosurgery, 236, Article ID: 108096. https://doi.org/10.1016/j.clineuro.2023.108096
|
[33]
|
Wang, M., Rajan, S.S., Jacob, A.P., Singh, N., Parker, S.A., Bowry, R., Grotta, J.C. and Yamal, J.M. (2020) Retrospective Collection of 90-Day Modified Rankin Scale Is Accurate. Clinical Trials (London, England), 17, 637-643.
https://doi.org/10.1177/1740774520942466
|
[34]
|
ElHabr, A.K., Katz, J.M., Wang, J., Bastani, M., Martinez, G., Gribko, M., Hughes, D.R. and Sanelli, P. (2021) Predicting 90-Day Modified Rankin Scale Score with Discharge In-formation in Acute Ischaemic Stroke Patients Following Treatment. BMJ Neurology Open, 3, e000177. https://doi.org/10.1136/bmjno-2021-000177
|